This from our UK toe and flowmigos. It tends to add up WIfI, which is not entirely the way it was intended to work, but the simplicity and completeness of this form is pretty great. Enjoy.
Pharmacist-led screening for diabetic peripheral neuropathy using the Michigan Neuropathy Screening Instrument (MNSI) #ActAgainstAmputation @ALPSlimb
A great idea from our Jordanian colleagues. Background Diabetic peripheral neuropathy (DPN) is highly prevalent among Jordanian patients, mostly are asymptomatic. Early recognition and appropriate management of neuropathy is important to improve symptoms, reduce sequelae, and improve quality of life. This study aims at exploring the role of pharmacists in the early recognition of DPN... Continue Reading →
Implementation of corneal confocal microscopy for screening and early detection of diabetic neuropathy in primary care alongside retinopathy #screening: Results from a feasibility study #DiabeticFoot @ALPSlimb
Continued strong work from our friends and colleagues making the link between the eyes and the sole Objective: Screening for diabetic peripheral neuropathy (DPN) is essential for early detection and timely intervention. Quantitative assessment of small nerve fiber damage is key to the early diagnosis and assessment of its progression. Corneal confocal microscopy (CCM) is a... Continue Reading →
Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: 75% Increased Risk for Declining Screening #ActAgainstAmputation @alpslimb
Important work from Wang and coworkers. This from a large population based cohort in the UK. Bottom line: screening matters and identifying those that decline foot exam can be life-extending Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study Aim: We aimed to... Continue Reading →